ACM
BEAM icon

Aquatic Capital Management’s Beam Therapeutics BEAM Stock Holding History

Aquatic Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Buy
+54,953
New +$1.52M 0.04% 496
2024
Q3 		– Sell
-6,100
Closed -$143K – 1157
2024
Q2 		$143K Sell
6,100
-1,800
-23% -$44.2K 0.01% 830
2024
Q1 		$261K Buy
+7,900
New +$246K 0.01% 703
2023
Q2 		– Sell
-23,300
Closed -$713K – 1342
2023
Q1 		$713K Buy
23,300
+8,700
+60% +$343K 0.04% 338
2022
Q4 		$567K Buy
+14,600
New +$654K 0.04% 472

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Aquatic Capital Management's BEAM Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 54,953 shares worth $1.31M. The stake represents 0.04% of the portfolio and ranks #496 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in BEAM as recently as Q2 2024.

Aquatic Capital Management first reported a position in BEAM in Q4 2022 and has held it in 5 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Aquatic Capital Management held 54,953 shares of Beam Therapeutics worth $1.31M as of Q1 2026.
  • Beam Therapeutics was a new Aquatic Capital Management position in Q1 2026.
  • Beam Therapeutics made up 0.04% of Aquatic Capital Management's portfolio in Q1 2026, its #496 holding.
  • Aquatic Capital Management first reported a position in Beam Therapeutics in Q4 2022 and has held it in 5 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.